EBR Systems, Inc. (EBRCZ) Stock
EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About EBR Systems, Inc.
EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle. This innovative approach aims to address and eliminate the typical difficulties associated with traditional wired leads, such as challenging insertion, unintended nerve activation, device displacement, complex removal procedures, and the need for frequent repositioning. The company was established in 2003 and operates from its headquarters in Sunnyvale, California.
EBR Systems, Inc. is headquartered in US.
EBR Systems, Inc. (EBRCZ) stock trades at $0.27 with a market capitalization of $172.39M. The stock is valued at a price-to-earnings (P/E) ratio of -2.82, price-to-book of 123.39, price-to-sales of 29.79. Over the past 52 weeks the stock has ranged between $0.19 and $1.50, and currently trades 82.0% below its 52-week high.
On profitability, EBR Systems, Inc. generates a return on equity (ROE) of -179.23%, return on capital employed of -76.63%, an operating margin of -2400.00%, a net profit margin of -2450.00%.
Official website: ebrsystemsinc.com